Director/PDMR Shareholding

21st Nov 2024 10:51

RNS Number : 1811N
Liontrust Asset Management PLC
21 November 2024
 

 

LEI: 549300XVXU6S7PLCL855

 

For immediate release

21 November 2024

 

Liontrust Asset Management Plc

 

("Liontrust" or the "Company")

 

Notification of transactions of persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA")

 

Liontrust announces that on 21 November 2024 it was notified that John Ions, Chief Executive Officer, purchased 60,000 ordinary shares of 1p each in the Company ("Shares") and his wife, Paige Ions, purchased 40,000 Shares. John Ions is a PDMR and Paige Ions is a PCA to Mr Ions.

 

Formal notification in respect of the PDMR and the PCA is set out below in accordance with the requirements of the Market Abuse Regulation.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

John Ions

2

 

Reason for the notification

 

a)

 

Position/status

 

PDMR (CEO)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Liontrust Asset Management Plc

b)

 

LEI

 

549300XVXU6S7PLCL855

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB0007388407

b)

 

Nature of the transaction

 

 

Purchase of Shares by the PDMR.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£4.50

60,000

 

 

d)

 

Aggregated information

- Aggregated volume

Not applicable

- Price

e)

 

Date of the transaction

 

21 November 2024

f)

 

Place of the transaction

 

London Stock Exchange

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Paige Ions

2

 

Reason for the notification

 

a)

 

Position/status

 

PCA to PDMR (CEO)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Liontrust Asset Management Plc

b)

 

LEI

 

549300XVXU6S7PLCL855

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB0007388407

b)

 

Nature of the transaction

 

 

Purchase of Shares by the PDMR.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£4.50

40,000

 

 

d)

 

Aggregated information

- Aggregated volume

Not applicable

- Price

e)

 

Date of the transaction

 

21 November 2024

f)

 

Place of the transaction

 

London Stock Exchange

 

 

For further information please contact:

 

Teneo (Tel: 020 7353 4200, Email: [email protected])

Tom Murray, Colette Cahill, Jessica Pine

 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.co.uk)

Stephen Corbett: Head of Investor Relations

Simon Hildrey: Chief Marketing Officer

 

Singer Capital Markets (Tel: 020 7496 3000)

Corporate Broking: Charles Leigh-Pemberton

Corporate Finance: James Moat

 

Panmure Liberum (Tel: 020 7886 2500)

Corporate Broking: David Watkins

Corporate Advisory: Atholl Tweedie

 

HSBC Bank plc (Tel: 020 7991 8888)

Corporate Broking: Simon Alexander, James Hopton

Corporate Advisory: Alexander Paul

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGBDBCSDDGSB